1. Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis

   • Stefano Censi
   • Giandomenico Bisaccia
   • Antonino Uncini

   Review Open access 17 January 2024 Pages: 1063 - 1071

   

2. Prognostic and relapsing factors of primary autoimmune cerebellar ataxia: a prospective cohort study

   • Mange Liu
   • Haitao Ren
   • Hongzhi Guan

   Original Communication 23 December 2023 Pages: 1072 - 1079

   

3. Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient

   • Chiara Briani
   • Alessandro Salvalaggio
   • Roberto Gasparotti

   Letter to the Editors 07 January 2024 Pages: 1080 - 1083

   

4. Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation

   • Gregory Feng
   • Stephanie Posa
   • Robert Simpson

   Review 14 January 2024 Pages: 1084 - 1107

   

5. Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review

   • Chia-Chen Tsai
   • Sophia Jette
   • Helen Tremlett

   Original Communication 11 December 2023 Pages: 1108 - 1123

   

6. The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial

   • Mohamed Y. Abdelgaied
   • Mohamed Hamed Rashad
   • Mohamed H. Solayman

   Original Communication 09 December 2023 Pages: 1124 - 1132

   

7. Predicting disease severity in multiple sclerosis using multimodal data and machine learning

   • Magi Andorra
   • Ana Freire
   • Pablo Villoslada

   Original Communication Open access 22 December 2023 Pages: 1133 - 1149

   

8. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

   • Pietro Iaffaldano
   • Giuseppe Lucisano
   • The Italian MS Register

   Original Communication 22 December 2023 Pages: 1150 - 1159

9. Blood pressure variability predicts poor outcomes in acute stroke patients without thrombolysis: a systematic review and meta-analysis

   • Yajing Chen
   • Yuxia Ma
   • Lin Han

   Review 30 November 2023 Pages: 1160 - 1169

   

10. Associations between olfactory dysfunction and cognition: a scoping review

    • Patricia T. Jacobson
    • Brandon J. Vilarello
    • Jonathan B. Overdevest

    Review 13 January 2024 Pages: 1170 - 1203

    

11. Clinical and functional characteristics, possible causes, and impact of chronic cough in patients with cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome (CANVAS)

    • Esther Palones
    • Elena Curto
    • Astrid Crespo-Lessmann

    Original Communication Open access 02 November 2023 Pages: 1204 - 1212

12. Muscle mass and chronic dizziness: a cross-sectional study of a Korean population

    • Eun Ji Kim
    • Hye Seon Jeong
    • Ji-Soo Kim

    Original Communication 01 November 2023 Pages: 1213 - 1223

    

13. Efficacy of the use of video games on mood, anxiety and depression in stroke patients: preliminary findings of a randomised controlled trial

    • Patricia Blázquez-González
    • Rubén Mirón-González
    • María Montserrat García-Sastre

    Original Communication Open access 10 January 2024 Pages: 1224 - 1234

    

14. Quantitative brainstem and spinal MRI in amyotrophic lateral sclerosis: implications for predicting noninvasive ventilation needs

    • M. Khamaysa
    • M. Lefort
    • The Pulse Study Group

    Original Communication 01 November 2023 Pages: 1235 - 1246

    

15. Cerebral glucose hypometabolism and hypoperfusion of cingulate gyrus: an imaging biomarker of autoimmune encephalitis with psychiatric symptoms

    • Yueqian Sun
    • Gongfei Li
    • Qun Wang

    Original Communication Open access 09 November 2023 Pages: 1247 - 1255

    

16. Immersive virtual reality-based rehabilitation for subacute stroke: a randomized controlled trial

    • Qianqian Huang
    • Xixi Jiang
    • Songhe Jiang

    Original Communication Open access 10 November 2023 Pages: 1256 - 1266

    

17. Neurological complications of excessive recreational nitrous oxide use: a case series based on a text mining algorithm

    • B. J. Ruijter
    • M. J. de Mooij
    • V. I. H. Kwa

    Original Communication 02 November 2023 Pages: 1267 - 1276

    

18. Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia

    • Imogen J. Swift
    • Simon Sjödin
    • Aitana Sogorb-Esteve

    Original Communication Open access 02 November 2023 Pages: 1277 - 1285

    

19. Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank

    • Min Peng
    • Shiqi Yuan
    • Anding Xu

    Original Communication 20 November 2023 Pages: 1286 - 1296

    

20. Comparison of CSF and plasma NfL and pNfH for Alzheimer’s disease diagnosis: a memory clinic study

    • Agathe Vrillon
    • Nicholas J. Ashton
    • Claire Paquet

    Original Communication 11 November 2023 Pages: 1297 - 1310

    

21. 10-year mortality, causes of death and cardiovascular comorbidities in idiopathic normal pressure hydrocephalus

    • Sanna A. Eklund
    • Hanna Israelsson
    • Jan Malm

    Original Communication Open access 02 November 2023 Pages: 1311 - 1319

    

22. Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88^L265P and CXCR4 mutations and underlying haemopathy

    • Alexandre Guérémy
    • José Boucraut
    • Emilien Delmont

    Original Communication 18 November 2023 Pages: 1320 - 1330

    

23. Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series

    • Alessia Pugliese
    • Adela Della Marina
    • Hanns Lochmüller

    Original Communication 04 November 2023 Pages: 1331 - 1341

    

24. Unveiling the SOD1-mediated ALS phenotype: insights from a comprehensive meta-analysis

    • Teuta Domi
    • Paride Schito
    • Yuri Matteo Falzone

    Original Communication 06 November 2023 Pages: 1342 - 1354

    

25. Clinical and genetic features of patients suffering from CMT4J

    • Sadia Beloribi-Djefaflia
    • Raul Juntas Morales
    • Shahram Attarian

    Original Communication 11 November 2023 Pages: 1355 - 1365

    

26. Safety and outcomes of different endovascular treatment techniques for anterior circulation ischaemic stroke in the elderly: data from the Imperial College Thrombectomy Registry

    • Lucio D’Anna
    • Lorenzo Barba
    • Kyriakos Lobotesis

    Original Communication Open access 20 November 2023 Pages: 1366 - 1375

27. Sex differences in outcomes of endovascular therapy for acute vertebrobasilar occlusion: data from ANGEL-ACT Registry

    • Xiaochuan Huo
    • Dapeng Sun
    • the ANGEL-ACT study group

    Original Communication 11 November 2023 Pages: 1376 - 1384

    

28. The prognostic value of systematic genetic screening in amyotrophic lateral sclerosis patients

    • Di He
    • Yining Liu
    • Liying Cui

    Original Communication 19 November 2023 Pages: 1385 - 1396

    

29. Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson’s disease

    • Dong-Woo Ryu
    • Sang-Won Yoo
    • Joong-Seok Kim

    Original Communication 09 November 2023 Pages: 1397 - 1407

    

30. Mechanisms underlying treatment effects of vestibular noise stimulation on postural instability in patients with bilateral vestibulopathy

    • Max Wuehr
    • Josefine Eder
    • Klaus Jahn

    Original Communication Open access 16 November 2023 Pages: 1408 - 1415

    

31. Macro- and micro-structural insights into primary dystonia: a UK Biobank study

    • Claire L. MacIver
    • Grace Bailey
    • Kathryn J. Peall

    Original Communication Open access 23 November 2023 Pages: 1416 - 1427

    

32. Cortical thickness modeling and variability in Alzheimer’s disease and frontotemporal dementia

    • Agnès Pérez-Millan
    • Sergi Borrego-Écija
    • Raquel Sánchez-Valle

    Original Communication Open access 27 November 2023 Pages: 1428 - 1438

    

33. Social cognition and behavioral changes in patients with posterior cortical atrophy

    • Marie-Anne St-Georges
    • Linshan Wang
    • Maxime Montembeault

    Original Communication 30 November 2023 Pages: 1439 - 1450

    

34. Amelioration of Parkinsonian tremor evoked by DBS: which role play cerebello-(sub)thalamic fiber tracts?

    • Daniel Deuter
    • Tobias Mederer
    • Jürgen Schlaier

    Original Communication Open access 30 November 2023 Pages: 1451 - 1461

    

35. Novel ultrasound neuromodulation therapy with transcranial pulse stimulation (TPS) in Parkinson’s disease: a first retrospective analysis

    • Sarah Osou
    • Sonja Radjenovic
    • Roland Beisteiner

    Short Commentary Open access 30 November 2023 Pages: 1462 - 1468

    

36. Meningoencephalitis and retinal vasculitis due to rickettsial infection

    • Louisa Lehner
    • Stephan Thurau
    • Michael Strupp

    Letter to the Editors Open access 24 November 2023 Pages: 1469 - 1472

    

37. Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)

    • Madeleine Hazard
    • Fanny Duval
    • Emilie Gérard

    Letter to the Editors 06 December 2023 Pages: 1473 - 1482

38. Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease

    • Beatrix Feigl
    • Simon J. G. Lewis
    • Oliver Rawashdeh

    Neurological Update Open access 09 November 2023 Pages: 1483 - 1491

    

39. Evaluating the performance of optically pumped magnetometers (OPM) in the diagnosis and presurgical workup of focal epilepsy

    • Phil Sequeiros
    • Khalid Hamandi

    Journal Club Open access 12 February 2024 Pages: 1492 - 1494

40. William Cumberland Cruikshank (1745–1800)

    • Meng-Syun Li

    Pioneers in Neurology 12 December 2023 Pages: 1495 - 1496